The news, distilled into what matters.

New Pancreatic Cancer Drug Doubles Survival Rate in Trials

  • Decades-in-the-making drug is being called a game-changer for pancreatic cancer.
  • Trial results showed it doubled patients’ survival time and slowed tumor progression.
  • Experts say it might also help treat other cancers — a hopeful topic for conversation.
Read full article

Get the full experience in the app — topics, comments, and audio summaries.

Download on the App Store Download on the App Store